Iroxanadine

• Target:

  HSP|||p38 MAPK

• Related Pathways:

  Metabolism|||Cytoskeletal Signaling|||MAPK

• Purity:

  >99.99%

• Bioactivity:

  Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.13480-84-5

• Smiles:

  C (C1NC (=NOC1) C=2C=CC=NC2) N3CCCCC3

• Molecular Formula:

  C14H20N4O

• Molecular Weight:

  260.33

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  203805-20-3